Midwest angel investment in life sciences on the rise
Angel investors fill a gap left by hesitant VCs. Michael Rosen looks at the five types of life-science angels and runs the numbers on their contribution to start-up businesses....
Angel investors fill a gap left by hesitant VCs. Michael Rosen looks at the five types of life-science angels and runs the numbers on their contribution to start-up businesses....
Madison, Wis. — State agencies have backed a new organization, the Wisconsin Angel Network, which would connect private investors in early-stage companies with entrepreneurs. The Wisconsin Technology Council, which advises the governor and Legistature on technology, would house the network and be its umbrella organization....
Prospective agriculture investors heard about using biomass and enzymes to produce hydrogen fuel, ethanol, and cancer treatments at the annual meeting of Badger AgVest in Lake Delton last Thursday....
Milwaukee — ZyStor Theraputics, Inc., has completed part of its $8.5 million financing and bought technology from St. Louis-based Symbiontics, Inc., for treating rare diseases, the company said....
Madison, Wis. — After two days of demostrating Wisconsin's breakthroughs in biotechnology, the Wisconsin Life Sciences and Venture Conference closed last Wednesday with a discussion of what the state must do to attract business. Without capital, they said, the state will not be able to...
Wisconsin is pulling its weight in life-sciences research, as presenters showed at the recent Life Sciences and Venture Conference. But where were all the VCs?...
Angel investors and venture capitalists were treated to an exhibition of Wisconsin’s continually evolving technology culture at the Wisconsin Life Sciences and Venture Conference, held Tuesday and Wednesday at the Monona Terrace....
Entrepreneurs who get attention, get capital. Wisconsin entrepreneurs need to learn to overcome a culture that encourages silence and get their story out....
A large Wisconsin investment has drawn a St. Louis biotech company to the Milwaukee County Research Park. The company is targeting a type of debilitating genetic disease that is often fatal, using a new technique....
Madison, Wis. — NimbleGen, a Madison biotech firm that played a leading role in determining the origins of the 2003 Severe Acute Respiratory Syndrome outbreak in Singapore has won $12.8 million in venture capital....